Tag: Ogsiveo for desmoid tumors

Home / Ogsiveo for desmoid tumors

Categories

Nirogacestat is approved by the USFDA for desmoid tumors

The Food and Drug Administration authorized nirogacestat (OGSIVEO, SpringWorks Therapeutics, Inc.) on November 27, 2023, for adult patients with advancing desmoid tumors needing systemic treatment. T...
ogsiveo-for-desmoid-tumors

Scan the code